182 related articles for article (PubMed ID: 3024873)
1. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Hirata Y; Nakashima H; Uchihashi M; Tomita M; Fujita T; Ikeda M
Endocrinol Jpn; 1984 Oct; 31(5):619-26. PubMed ID: 6097444
[TBL] [Abstract][Full Text] [Related]
3. Ovine corticotrophin releasing factor stimulates ACTH release from human corticotrophinoma cells in culture; interaction with hydrocortisone and arginine vasopressin.
White MC; Adams EF; Loizou M; Mashiter K; Fahlbusch R
Clin Endocrinol (Oxf); 1985 Sep; 23(3):295-302. PubMed ID: 3000651
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
5. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
Ishibashi M; Yamaji T
J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
[TBL] [Abstract][Full Text] [Related]
6. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
7. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ
J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109
[TBL] [Abstract][Full Text] [Related]
9. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
Elias AN; Gwinup G; Valenta LJ
Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
[TBL] [Abstract][Full Text] [Related]
11. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
[TBL] [Abstract][Full Text] [Related]
12. Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin-releasing factor following sodium valproate administration in a patient with Nelson's syndrome.
Gomi M; Iida S; Itoh Y; Moriwaki K; Kanayama S; Namba M; Tarui S
Clin Endocrinol (Oxf); 1985 Aug; 23(2):123-7. PubMed ID: 2996808
[TBL] [Abstract][Full Text] [Related]
13. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
[TBL] [Abstract][Full Text] [Related]
14. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone inhibits ovine corticotrophin-releasing factor (oCRF), arginine vasopressin (AVP), and oCRF + AVP stimulated release of ACTH during the last third of pregnancy in the sheep fetus.
Norman LJ; Challis JR
Can J Physiol Pharmacol; 1987 Jun; 65(6):1186-92. PubMed ID: 3040203
[TBL] [Abstract][Full Text] [Related]
16. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies with synthetic ovine corticotropin-releasing factor.
Orth DN; DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Uderman H; Alexander AN; Island DP; Rivier J
Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
